HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Body Shop

This article was originally published in The Rose Sheet

Executive Summary

Hemp body care line for dry to very dry skin contains "high levels" of essential fatty acids, including gamma-linoleic acid to hydrate skin, the retailer said. The five products also contain sesame and sweet almond oil for emollient benefits. Hemp 3 in 1 Oil has multiple uses as a bath, massage or body oil. Hand Protector contains lanolin, glycerin and pro-vitamin B5 to moisturize, while Lip Conditioner balm is formulated with beeswax and carnuba wax to soothe and protect lips. Elbow Grease combines avocado, jojoba, soya oil and beeswax to treat dry patches. The line also includes Hemp Soap to cleanse and exfoliate. The Body Shop is promoting the line with large window displays entitled "hemp revival for skin survival." The lip product and soap cost $4.95 and the remaining products are priced at $9.95...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel